asset,query,published_at_utc,title,summary,url,source
Novo Nordisk,Novo Nordisk,2025-10-27T21:40:14Z,Novo Nordisk’s Safety Study on Turoctocog Alfa Pegol: Key Insights for Investors - TipRanks,,https://news.google.com/rss/articles/CBMiygFBVV95cUxPUmxzR1czdDhzWWpFTFpvSG9RaXE4V19KdVVVSGR1cXJfRkJFaFlRY2RJcHV6ZE1xVDBRSnRfME5VX0x5MHRzNFAxQ3d6M3ItNk9FOElBVmt5WFh2Q1EwSUF3UVRIQVgtVXY0Q1JMSlRrTTNqZkVHUkZYamdsdV8zbkhRWmhXTk5BSWtINENGV3ByLWd1Z1JXa0N3Y2JZc1F4ck1JckhhUENWOGlNd1U4dm1ET2dXWm0xdGRqZ3FaLW5KWDZ2OHdkN0J3?oc=5,gnews
Novo Nordisk,Novo Nordisk,2025-10-27T21:40:14Z,Novo Nordisk’s Latest Diabetes Study: A Potential Game-Changer? - TipRanks,,https://news.google.com/rss/articles/CBMisgFBVV95cUxNV2tvNFI2Ml9saUtyTVdBbHFXRTJHbkd2UF9QN3o3WlBVb2lYTDRhRG5Qek1uellidy1LaUJ6RjBiTDlGQWo1SG90U1VicGRfWlVoRWtNNkotWEl5TkswMHhMV1VPaWRRVXFxSXlWbTZFSTFseDBWaWFELWRHN2xmRnNTSFhRUXdaaHRyVFpPVTFHdTZDcFJIN3NZYUxBTU1QUXNlaFJTR1VMSFFtNl9ZMVdB?oc=5,gnews
Novo Nordisk,Novo Nordisk,2025-10-27T21:40:14Z,Novo Nordisk’s Real-World Study on Semaglutide: Implications for Obesity Management - TipRanks,,https://news.google.com/rss/articles/CBMizgFBVV95cUxNSE5oZlRJemk2NmQ0dlptY2x6UlRNWGxxN0xBVW1RRDhna2w5RXVQNkRCREhOTXhqQlQ3X183eU5UZkR5S1hOV3VHWFhGeFdpVzMxcF9iYzE5WEU3M096dHRRcWN4bHpZUFdKMlRDSzZRTnhkTkZ3WURLVGNaSndreU5TeGxqTWt2LWFiY0JVMDIxdFhhbGFUek5jdmU0aGtXUHpvcFdfeWVHSUNjV3c1bDJnd2dRN3hsRDQ5WWg5MFd2YldVdXdnYTRmRFlVUQ?oc=5,gnews
Novo Nordisk,Novo Nordisk,2025-10-27T21:40:14Z,Novo Nordisk’s Real-World Study on Wegovy: A Potential Game Changer in Obesity Management - TipRanks,,https://news.google.com/rss/articles/CBMi1gFBVV95cUxNVWFhV1NkYTcyeUlVQ3pZOWt4VlNLbFBtS3VHSmZjSWVmSms1NlRyRUZBdUFsdHBwU2d5R2Jfd3FzUloxXzc4cUtFenpfdnN3VVNBQXc3VnNVbXYyY3ZrdlhaNGJKbTFqX1BwM05WT2pVdDFSdk5aaVQyRzRLdS1TYlZvUDJsZzUzVkJOcWZWNlBoYzZBdkFvOGJ0N1RtZXc4dTBlTnZSOW5XSzlhNHVqUVNEbXdlc1JnMS1rOVVjQzN1V0wySkFlUkJndXNRTGR0al9VRTl3?oc=5,gnews
Novo Nordisk,Novo Nordisk,2025-10-27T21:40:14Z,Novo Nordisk’s Norditropin® Study: A Closer Look at Its Impact on Noonan Syndrome - TipRanks,,https://news.google.com/rss/articles/CBMiygFBVV95cUxQU0Z4N1lzdW4zckFidndQZ3ExRTdZMTlSb2w2T3JYRF9yR0UyLUpDMXI1RkNkcDNtM1E3VGpuSHVvN014ME4xaE9Pem94QWh1Y3J1Rnc0Ym5tU2pSTDU2NjVUel9jOVI3NzdVSllydU5BTjM1RVpjUjd0WExqVEV2bDhDdlo0SWQ4Y043cjRublI0UFBXeUtueXhRdEY3elVva3laNmpsSk1TcUxhaTVlTnJXcm4wc1AtNnItOHRHMTNrNmN3eS0wcWhR?oc=5,gnews
Novo Nordisk,Novo Nordisk,2025-10-27T21:40:14Z,Novo Nordisk’s Study on Norditropin®: Impact on Growth Hormone Therapy Adherence - TipRanks,,https://news.google.com/rss/articles/CBMiyAFBVV95cUxON1lib2M5Rl80MThVUFdtT01hR3FDeVRyZnhzX1VlUXhUanBUWWltOE9JOFZMS2VKRDY2QWMxcEhjbzY3YU5CZWNIb1BoYkJsMnpMVlFtNU03c1BpZjB2VXZ4Z2hCd2FyTGN1WVBFNDMySlZFMUp5cjRPNWNFOEJ3RGIzdVhFLVRQWElWb1laQkdmTzgzcnIwQ0RRd001M2RYSWp3NmZFMFZ2bW5ET0doVWZFN0dXdi1LczkwQUhBZFZ3RWNMRzFiYw?oc=5,gnews
Novo Nordisk,Novo Nordisk,2025-10-27T21:40:13Z,Novo Nordisk’s Ongoing Observational Study on Parkinson’s Disease: Key Insights for Investors - TipRanks,,https://news.google.com/rss/articles/CBMi2gFBVV95cUxPZUFaMkVFYnhyZlc2R05zdEdzcE1lNDJVSkNkdEJUUEN0RGhLczlhQkdaUGI0Q0RrcXNjWnBOMW1XSGZxbHJMYi1UWGNORnBqaS0zQUpDMFUzOUZxWG9Ia0d0Q1JzOTJaWUlVTzhUT3RFVnVKZUZhWmNYQWlVY1psdjdFLXAzSXd6M0pPNjlDd1FuNDZnRXVha0RsVDRmS1JzWWVycGFSWlFJNzNZZDQtdDJ0d2pzQnFoZnlMNEo2WTJ6N2xpbnRyQ2NmNkdtSFdoWENJZ0lKX09oUQ?oc=5,gnews
Bitcoin,BTC Bitcoin,2025-10-27T21:36:33Z,"American Bitcoin Reports 3,865 BTC in Reserves Following Latest Acquisition - Bitcoin.com News",,https://news.google.com/rss/articles/CBMiogFBVV95cUxPMFZTSVBLNEt1MUlBbGJwUzN1NHlvZ0ZVZEhtc2EzWnk0NEFaR2tlaHhsSHhYV21aNklyRTZZakpBN3NmZkw2aklDQlpwZF9RX3RxakVLNUJWQVRWVGRWaExGclVmWE5yRHNTNUZ5XzFqUVh6c0FuamJDWkN4cnA0ZEdVc1h4enZXNl9BNkVFc3g1QXBkRzFLVGVVR2FyOHduSGc?oc=5,gnews
Novo Nordisk,Novo Nordisk,2025-10-27T21:29:51Z,Novo Nordisk Advances Sickle Cell Treatment with Etavopivat Study - TipRanks,,https://news.google.com/rss/articles/CBMiuAFBVV95cUxOa2NjcVpVLXRnN3Njbkk0T1JmWVR6ZEdqX1V4Qmh4b1F3aldLSjd4d2g1QjB6dlVIMzN6clFjVWk5Q3Z3QzFtLWQ4VEhJcmlxdmtKX2R4bndwNTRDcGNaMWFRdTJVM2FoREJhaG5iZGFLbE4xZFFxSDdYblp5MC1JcnJTSDJ3RG9FSHpXcTRjNUU0ZlQya3NxdkZKLXFFVWJUMWJSdFh4bHJLZlJpNkZvYXpRUHI4MFVE?oc=5,gnews
